13F HOLDINGS REPORT
Cormorant Asset Management, LP
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0001583977-24-000003
Total Value
$1.73B
Positions
49
Other Managers
1
Confidential Omitted
No
Holdings (49)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 8,494,151 | $373.5M | 21.58% |
| 2 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 2,025,000 | $91.6M | 5.29% |
| 3 | ARCELLX INC | ACLX | 1,525,000 | $84.2M | 4.86% |
| 4 | VAXCYTE INC | PCVX | 1,100,000 | $83.1M | 4.80% |
| 5 | LONGBOARD PHARMACEUTICALS IN | 54300N103 | 2,790,462 | $75.4M | 4.36% |
| 6 | EYEPOINT PHARMACEUTICALS INC | EYPT | 8,325,000 | $72.4M | 4.18% |
| 7 | RAPPORT THERAPEUTICS INC | RAPP | 2,940,283 | $68.4M | 3.95% |
| 8 | CRINETICS PHARMACEUTICALS IN | CRNX | 1,350,000 | $60.5M | 3.49% |
| 9 | EDGEWISE THERAPEUTICS INC | EWTX | 3,006,534 | $54.1M | 3.13% |
| 10 | MERUS N V | N5749R100 | 840,000 | $49.7M | 2.87% |
| 11 | BRIDGEBIO PHARMA INC | BBIO | 1,858,351 | $47.1M | 2.72% |
| 12 | INSMED INC | INSM | 675,000 | $45.2M | 2.61% |
| 13 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 2,300,000 | $44.2M | 2.55% |
| 14 | JANUX THERAPEUTICS INC | JANX | 1,050,000 | $44.0M | 2.54% |
| 15 | AXSOME THERAPEUTICS INC | AXSM | 400,000 | $32.2M | 1.86% |
| 16 | CG ONCOLOGY INC | CGON | 975,000 | $30.8M | 1.78% |
| 17 | HELIX ACQUISITION CORP II | HLXC | 2,909,000 | $29.7M | 1.72% |
| 18 | ALUMIS INC | ALMS | 2,147,400 | $28.6M | 1.65% |
| 19 | PRAXIS PRECISION MEDICINES I | PRAX | 685,000 | $28.3M | 1.64% |
| 20 | ABIVAX SA | AAVXF | 2,130,000 | $28.2M | 1.63% |
| 21 | BIOHAVEN LTD | BHVN | 801,963 | $27.8M | 1.61% |
| 22 | UROGEN PHARMA LTD | URGN | 1,650,000 | $27.7M | 1.60% |
| 23 | PHARVARIS N V | PHVS | 1,466,460 | $27.6M | 1.59% |
| 24 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 2,525,000 | $23.5M | 1.36% |
| 25 | SAREPTA THERAPEUTICS INC | SRPT | 125,000 | $19.8M | 1.14% |
| 26 | CULLINAN THERAPEUTICS INC | CGEM | 1,125,000 | $19.6M | 1.13% |
| 27 | RHYTHM PHARMACEUTICALS INC | RYTM | 475,000 | $19.5M | 1.13% |
| 28 | CARGO THERAPEUTICS INC | 14179K101 | 1,182,563 | $19.4M | 1.12% |
| 29 | Y-MABS THERAPEUTICS INC | 984241109 | 1,450,000 | $17.5M | 1.01% |
| 30 | AVIDITY BIOSCIENCES INC | 05370A108 | 425,000 | $17.4M | 1.00% |
| 31 | BIOMEA FUSION INC | BMEA | 3,570,872 | $16.1M | 0.93% |
| 32 | CENTESSA PHARMACEUTICALS PLC | CNTA | 1,611,600 | $14.6M | 0.84% |
| 33 | TARSUS PHARMACEUTICALS INC | TARS | 500,000 | $13.6M | 0.79% |
| 34 | SILENCE THERAPEUTICS PLC | SLNCF | 625,000 | $11.9M | 0.69% |
| 35 | ARRIVENT BIOPHARMA INC | AVBP | 515,000 | $9.6M | 0.55% |
| 36 | ENGENE HOLDINGS INC | ENGNW | 1,000,000 | $9.4M | 0.54% |
| 37 | KORRO BIO INC | KRRO | 265,826 | $9.0M | 0.52% |
| 38 | IDEAYA BIOSCIENCES INC | IDYA | 245,000 | $8.6M | 0.50% |
| 39 | IMMUNITYBIO INC | IBRX | 1,250,000 | $7.9M | 0.46% |
| 40 | GH RESEARCH PLC | GHRS | 593,043 | $6.9M | 0.40% |
| 41 | LANTHEUS HLDGS INC | LNTH | 75,000 | $6.0M | 0.35% |
| 42 | STOKE THERAPEUTICS INC | STOK | 427,163 | $5.8M | 0.33% |
| 43 | MERSANA THERAPEUTICS INC | 59045L106 | 2,600,000 | $5.2M | 0.30% |
| 44 | NEUROGENE INC | NGNE | 107,344 | $3.9M | 0.23% |
| 45 | SIGA TECHNOLOGIES INC | SIGA | 500,000 | $3.8M | 0.22% |
| 46 | VYNE THERAPEUTICS INC | VYNE | 1,394,336 | $2.7M | 0.16% |
| 47 | COMPASS THERAPEUTICS INC | CMPX | 2,030,823 | $2.0M | 0.12% |
| 48 | VERVE THERAPEUTICS INC | 92539P101 | 350,000 | $1.7M | 0.10% |
| 49 | RAPT THERAPEUTICS INC | 75382E109 | 496,750 | $1.5M | 0.09% |